Knig, D., Kohl, J., Jerger, S., & Centner, C
Among these, liraglutide in the LEADER study, semaglutide in the SUSTAIN-6, albiglutide in the Harmony Outcomes, dulaglutide in the REWIND, and efpeglenatide in the AMPLITUDE-O exhibited significant beneficial effects on 3-point major adverse cardiac events (3P-MACE: death from CV disease, non-fatal myocardial infarction, and non-fatal stroke), the primary end point of each study, compared to the placebo group, respectively
FREE from: gluten, lactose, soy, sugar, egg, fish, crustaceans, nuts, peanuts, mustard, celery, sesame, sulphite, lupin, molluscs, genetically modified ingredients (GMO), artificial flavourings, colourings and flavour enhancers
Chemical testing measures purity levels, drying loss, ash content, and solvent residues, confirming that the Copper Peptide Ghk Cu Powder meets cosmetic-grade specifications suitable for personal care applications